Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about OLIGODENDROCYTES: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
OLIGODENDROCYTES is a concept in neurodegeneration research. Key relationships include: co discussed, expressed in, activates. Associated with CANCER, DEMENTIA, NEURODEGENERATION. Connected to 80 entities in the SciDEX knowledge graph.
No AI portrait yet
| Name | OLIGODENDROCYTES |
| Key Genes/Proteins | ABCA1, ACHE, AD, ADAM10, ALS, ALZHEIMER |
| Related Diseases | Alzheimer'S Disease, ALZHEIMER'S DISEASE, AMYOTROPHIC LATERAL SCLEROSIS |
Knowledge base pages for this entity
graph TD
OLIGODENDROCYTES["OLIGODENDROCYTES"]
OLIGODENDROCYTES -->|"produces"| myelin["myelin"]
OLIGODENDROCYTES -->|"expressed in"| Prosaposin["Prosaposin"]
OLIGODENDROCYTES -->|"activates"| NEUROINFLAMMATION["NEUROINFLAMMATION"]
OLIGODENDROCYTES -->|"causes"| NEURODEGENERATION["NEURODEGENERATION"]
OLIGODENDROCYTES -->|"activates"| neuroinflammation["neuroinflammation"]
OLIGODENDROCYTES -->|"activates"| neurodegeneration["neurodegeneration"]
OLIGODENDROCYTES -->|"secretes"| IL6["IL6"]
OLIGODENDROCYTES -->|"causes"| PARKIN["PARKIN"]
OLIGODENDROCYTES -->|"causes"| PARKINSON["PARKINSON"]
OLIGODENDROCYTES -->|"causes"| PARKINSON_S["PARKINSON'S"]
HSPA1A["HSPA1A"] -->|"expressed in"| OLIGODENDROCYTES
Microglia["Microglia"] -->|"interacts"| OLIGODENDROCYTES
OxPC["OxPC"] -->|"causes"| OLIGODENDROCYTES
BIN1["BIN1"] -->|"expressed in"| OLIGODENDROCYTES
GPR37["GPR37"] -->|"expressed in"| OLIGODENDROCYTES
DOPAMINERGIC_NEURONS["DOPAMINERGIC_NEURONS"] -->|"interacts"| OLIGODENDROCYTES
OXPCS["OXPCS"] -->|"inhibits"| OLIGODENDROCYTES
OxPCs["OxPCs"] -->|"causes"| OLIGODENDROCYTES
AQP4["AQP4"] -->|"activates"| OLIGODENDROCYTES
ASTROCYTE["ASTROCYTE"] -->|"activates"| OLIGODENDROCYTES
ASTROCYTES["ASTROCYTES"] -->|"activates"| OLIGODENDROCYTES
COMPLEMENT["COMPLEMENT"] -->|"activates"| OLIGODENDROCYTES| Target | Relation | Type | Str |
|---|---|---|---|
| ds-f2c28aed24a7 | data_in | dataset | 1.00 |
| ds-f2c28aed24a7 | provides_data_for | dataset | 1.00 |
| Alzheimer's Disease | involved_in | disease | 0.95 |
| Neurodegeneration | associated_with | process | 0.95 |
| Metabolic Reallocation | involved_in | process | 0.95 |
| Myelin | associated_with | process | 0.95 |
| Neuroinflammation | associated_with | process | 0.95 |
| Neuroinflammation | causes | process | 0.95 |
| myelin | produces | protein | 0.90 |
| TAU | interacts_with | protein | 0.90 |
| Alzheimer's Disease Pathogenesis | contributes_to | process | 0.90 |
| Amyloid Pathology | interacts_with | process | 0.90 |
| Tau Pathology | interacts_with | process | 0.90 |
| Myelin Degeneration | contributes_to | process | 0.90 |
| multiple sclerosis | associated_with | disease | 0.90 |
| Parkinson's Disease | contributes_to | disease | 0.90 |
| Neurodegeneration | mediates | process | 0.90 |
| Neuroinflammation | mediates | process | 0.90 |
| Stress Response | associated_with | process | 0.85 |
| Disease Progression | contributes_to | process | 0.85 |
| Immune Modulation | mediates | process | 0.85 |
| Alzheimer'S Disease | contributes_to | disease | 0.85 |
| Inflammation | modulates | process | 0.85 |
| sphingolipid metabolism | active_in | pathway | 0.85 |
| Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease | involved_in | disease | 0.85 |
| Brain Ageing | associated_with | process | 0.85 |
| Dna Damage Response | expressed_in | pathway | 0.85 |
| Vascular Dementia | involved_in | disease | 0.85 |
| neurodegeneration | associated_with | process | 0.80 |
| multiple sclerosis | inhibits | disease | 0.80 |
| Synaptic Dysfunction | contributes_to | process | 0.80 |
| multiple sclerosis | activates | disease | 0.80 |
| MS lesions | expressed_in | process | 0.80 |
| Prosaposin | expressed_in | protein | 0.80 |
| Cellular Survival | mediates | process | 0.80 |
| NEUROINFLAMMATION | drives | process | 0.80 |
| demyelination | implicated_in | process | 0.80 |
| Oxidative Stress | involved_in | process | 0.80 |
| neurons | interacts_with | cell_type | 0.80 |
| Alzheimer'S Disease | protects_against | disease | 0.80 |
| Apoptosis | protects_against | process | 0.75 |
| unfolded protein response | active_in | pathway | 0.75 |
| COHESIN COMPLEX | expressed_in | protein | 0.75 |
| Defense Mechanisms | mediates | process | 0.75 |
| neurodegeneration | activates | phenotype | 0.72 |
| NEUROINFLAMMATION | activates | phenotype | 0.72 |
| NEURODEGENERATION | causes | phenotype | 0.72 |
| neuroinflammation | activates | phenotype | 0.72 |
| NEURODEGENERATION | activates | phenotype | 0.72 |
| TREM2 | activates | gene | 0.70 |
| Source | Relation | Type | Str |
|---|---|---|---|
| ds-f2c28aed24a7 | data_in | dataset | 1.00 |
| NEURON | activates | cell_type | 0.95 |
| MICROGLIA | regulates | cell_type | 0.95 |
| NEURON | regulates | cell_type | 0.95 |
| FERROPTOSIS | affects | process | 0.90 |
| MOG | expressed_in | gene | 0.90 |
| Oxidized Phosphatidylcholines | mediates | compound | 0.90 |
| OxPC | mediates | compound | 0.90 |
| 33440165 | shuttle | paper | 0.90 |
| neuroinflammation | affects | disease | 0.90 |
| unfolded protein response | active_in | pathway | 0.90 |
| SMS2 | expressed_in | gene | 0.90 |
| 36385529 | aberrantly deposited in | paper | 0.90 |
| aging | affects | disease | 0.90 |
| Alzheimer's disease | affects | disease | 0.90 |
| Oligodendrocyte Precursor Cells | involved_in | cell_type | 0.90 |
| lipid metabolism | active_in | pathway | 0.90 |
| multiple sclerosis | affects | disease | 0.90 |
| BDNF | promotes | gene | 0.90 |
| Oxidized Phosphatidylcholines | targets | compound | 0.90 |
| 38503282 | accumulate sSNVs faster than | paper | 0.90 |
| 38503282 | accumulate indels slower than | paper | 0.90 |
| 38503282 | accumulated indels slower than | paper | 0.90 |
| axon | found_in | organelle | 0.90 |
| HSPA1A | expressed_in | gene | 0.90 |
| 38503282 | accumulated sSNVs faster than | paper | 0.90 |
| neurodegeneration | affects | disease | 0.90 |
| 34225562 | show vulnerability and myelin alterations | paper | 0.90 |
| GPR37 | expressed_in | gene | 0.88 |
| GBA1 | expressed_in | gene | 0.85 |
| Oligonucleotide Transport Vehicle | expressed_in | drug | 0.85 |
| Microglia | interacts_with | cell_type | 0.85 |
| PIEZO1 | regulates | protein | 0.85 |
| Astrocytes | interacts_with | cell_type | 0.85 |
| AQP4 | expressed_in | gene | 0.80 |
| RNA | expressed_in | gene | 0.80 |
| SGMS1 | regulates | gene | 0.80 |
| BIN1 | expressed_in | protein | 0.80 |
| NLRP3 | regulates | gene | 0.80 |
| complement cascade | active_in | pathway | 0.80 |
| pyroptosis | active_in | pathway | 0.80 |
| NLRP3 | activates | gene | 0.80 |
| OxPC | causes | chemical | 0.80 |
| BIN1 | expressed_in | gene | 0.80 |
| MBP | expressed_in | gene | 0.80 |
| Parkinson's disease | affects | disease | 0.80 |
| Remyelinating Agents | targets | drug | 0.80 |
| Piezo1 | regulates | gene | 0.80 |
| NLRP3 | expressed_in | gene | 0.80 |
| SMPD1 | expressed_in | gene | 0.80 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| ACSL4-Ferroptotic Priming in Stressed Oligodendrocytes Drive | 0.801 | Alzheimer's Disease | Cell type vulnerability in Alzheimers Di |
| ACSL4-Driven Ferroptotic Priming in Disease-Associated Oligo | 0.779 | Alzheimer's Disease | Cell type vulnerability in Alzheimers Di |
| ALOX15-Driven Enzymatic Ferroptosis in AD Oligodendrocytes v | 0.772 | Alzheimer's Disease | Cell type vulnerability in Alzheimers Di |
| PDE4 Inhibition as Inflammatory Reset for PD Oligodendrocyte | 0.749 | neuroinflammation | How do oligodendrocytes initiate neuroin |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-03 | 43 hypotheses Top: 0.893
neurodegeneration | 2026-04-03 | 1 hypotheses Top: 0.606
neurodegeneration | 2026-04-03 | 19 hypotheses Top: 0.869
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| SIRPα modulation in mouse models of Alzheimer's disease | validation | Alzheimer's disease | 0.900 | 0.00 | mouse models of Alzheimer's di | proposed | N/A |
| Microglial SIRPα expression in human Alzheimer's disease tissue | exploratory | Alzheimer's disease | 0.800 | 0.00 | human brain tissue | proposed | N/A |
| Bioinformatics analysis and hub gene identification | exploratory | Alzheimer's disease | 0.800 | 0.00 | computational analysis of tran | proposed | N/A |
| Molecular docking analysis of aminophylline binding targets | exploratory | depression | 0.800 | 0.00 | in silico molecular docking | proposed | N/A |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Inflammatory Processes in Alzheimer's Disease-Pathomechanism, Diagnosis and Trea [PMID:37047492] | Unknown | Int J Mol Sci | 2023 | 0 |
| Pathogenesis of Alzheimer's Disease. [PMID:36613544] | Unknown | Int J Mol Sci | 2022 | 0 |
| Alzheimer's disease. [PMID:31753135] | ["Soria Lopez, Jose A", "Gonz\u00e1lez, | Handbook of clinical neurology | 2019 | 0 |
| Alzheimer's disease. [PMID:28872215] | ["Lane, C A", "Hardy, J", "Schott, J M"] | European journal of neurology | 2018 | 0 |
| Current understanding of Alzheimer's disease diagnosis and treatment. [PMID:30135715] | ["Weller, Jason", "Budson, Andrew"] | F1000Research | 2018 | 0 |
Multi-agent debates referencing this entity
closed · Rounds: 4 · Score: 0.12 · 2026-04-27
closed · Rounds: 4 · Score: 0.42 · 2026-04-27
closed · Rounds: 4 · Score: 0.48 · 2026-04-27
closed · Rounds: 4 · Score: 0.47 · 2026-04-27
closed · Rounds: 4 · Score: 0.52 · 2026-04-27
closed · Rounds: 4 · Score: 0.72 · 2026-04-27
closed · Rounds: 4 · Score: 0.95 · 2026-04-03
closed · Rounds: 4 · Score: 0.92 · 2026-04-03
closed · Rounds: 4 · Score: 0.90 · 2026-04-03
Hypotheses and analyses mentioning OLIGODENDROCYTES in their description or question text
No additional research found